Advertisement

FDA: Clinicians Should Not Prescribe High-Dose Acetaminophen Products — Physician’s First Watch

Medical News |
January 16, 2014

FDA: Clinicians Should Not Prescribe High-Dose Acetaminophen Products

By Kristin J. Kelley

Healthcare professionals should not prescribe combination drugs that contain more than 325 mg of acetaminophen per tablet or capsule, the FDA advised on Tuesday in an effort to reduce patient risk for liver injury from accidental overdose.

Nearly half of acetaminophen-related liver failure cases in the U.S. are caused by accidental overdose from prescription combination drugs, the agency said. In particular, severe liver injury has occurred in three common scenarios, when patients:

  • took more than the prescribed dose of an acetaminophen-containing product in a 24-hour period;

  • took more than one acetaminophen-containing product at the same time;

  • drank alcohol while taking acetaminophen products.

Moreover, according to FDA data, the benefits of taking more than the recommended dose do not outweigh the added risks.

In 2011, the FDA asked manufacturers to limit acetaminophen doses to no more than 325 mg per pill by January 14, 2014, but some products are still on the market.

Reader Comments (9)

Emmanuel Tigalya

FDA should also provide guidance on alternative agents where patients rely on acetaminophen to manage pain on a daily basis.

alfredo casaliba Physician, Nephrology, hospital

Already known but very good

Alaa

That's very important & useful info to reduse liver transplant

Gustavo Adrián Isacaz Physician, Internal Medicine

In the case of acetaminophen, less is better.

Ronald K Rogers MD Physician, Psychiatry, Retired

I agree 100%

SWAMINATHAN RAMKUMAR

does this apply only to combinations or to plain acetaminophen as well?

Junior Destine MD Medical Student, Family Medicine/General Practice, Clinical & Herbal Innovation Inc

I am really happy about the fact that this is being prevented now!..

Benjamin B Okel, MD

That's very important info that has not been sufficiently emphasized.
Thank you.

Marc Tanenbaum, MD Physician, Pediatrics/Adolescent Medicine

I have long thought that the FDA should prohibit acetaminophen from being included in pediatric liquid combination products for cough and cold medications for the same reason.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement